Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INX-08189 in Chronic Genotype 1 HCV
NCT01445795Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Sep 2011
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of BMS-986094 in hepatitis C (HCV), sponsored by Bristol Myers Squibb. Started Sep 2011; status: completed.
02
Drugs
BMS-986094
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01445795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01445795.